Study supports value of sigmoidoscopy, an alternative to colonoscopy
May 21, 2012 By Randy Dotinga, HealthDay Reporter in Cancer
Research suggests the test can help prevent colon cancer incidence, deaths.
(HealthDay) -- New research confirms that sigmoidoscopies -- less-invasive alternatives to colonoscopies that don't require sedation -- are effective in lowering the risk of colon cancer.
Having the procedure lowered the risk of getting a colon cancer diagnosis by 21 percent and the chances of dying from the disease by 26 percent, the researchers reported.
Many doctors no longer offer sigmoidoscopies, but an editorial accompanying the study pointed out that sigmoidoscopies are still a good option for some patients.
"Physicians need to find out which colorectal cancer screening test the patient sitting in front of them will do, and recommend that test," said editorial author Dr. John Inadomi, a professor of medicine at the University of Washington School of Medicine in Seattle. "It's the test the patient wants to do -- not the test the doctor wants them to do -- that is important."
Colon and rectal cancers kill more than 51,000 people a year in the United States, according to the National Cancer Institute. Colonoscopies allow doctors to view the lining of the entire colon as they engage in search-and-destroy missions against polyps that could develop into cancer.
Sigmoidoscopies use a smaller scope that searches only the lower colon, potentially missing some precancerous polyps. Patients can return to home or work right after the procedure because they are not sedated.
Both kinds of screening require a notoriously unpleasant cleansing of the colon via a liquid laxative. However, sigmoidoscopies require less laxative consumption than colonoscopies, Inadomi said.
But there is a hitch to sigmoidoscopies: If the procedure turns up potentially dangerous polyps, they need to be removed during a subsequent colonoscopy.
In the new study, researchers randomly assigned half of 154,900 people aged 55 to 74 to sigmoidoscopies -- 84 percent actually got them -- and tried to get those patients to return for a second sigmoidoscopy three to five years later. The study lasted from 1993 to 2001.
The risk of colon cancer deaths in the patients overall was small -- 593 occurred over an average of 12 years of follow-up. But the risk fell by 26 percent in those who had the procedures compared to people in the usual care group, who only got colonoscopies or sigmoidoscopies if they asked for one or their doctor recommended one. The researchers estimated that if they had used colonoscopies rather than sigmoidoscopies in their study, they would have spotted 16 percent more cancers.
However, the researchers discovered that even colonoscopies sometimes failed to find precancerous polyps.
When it comes to the ability of regular colonoscopies to detect polyps, "we may have to do better," said study author Dr. Robert Schoen, a professor of medicine and epidemiology at the University of Pittsburgh School of Medicine. "Or maybe we can't do better."
The study appears online May 21 in the New England Journal of Medicine, to coincide with a presentation at the annual Digestive Diseases Week meeting in Chicago.
More information: For more about colon cancer, try the U.S. National Library of Medicine.
Journal reference:
New England Journal of Medicine
Copyright © 2012 HealthDay. All rights reserved.
-
Study: Colonoscopy cuts colon cancer death risk
Feb 22, 2012 |
not rated yet |
0
-
Study: Simple scope exam cuts colon cancer deaths
May 21, 2012 |
not rated yet |
0
-
Poor colonoscopy prep hides pre-cancerous polyps
Mar 27, 2012 |
not rated yet |
0
-
Colonoscopies by primary-care doctors safe, study finds
Aug 11, 2010 |
not rated yet |
0
-
Prostate cancer patients are at increased risk of precancerous colon polyps
Oct 19, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Hormone replacement therapy—clarity at last
The British Menopause Society and Women's Health Concern have today released updated guidelines on Hormone Replacement Therapy (HRT) to provide clarity around the role of HRT, the benefits and the risks. The new guidelines ...
Cancer
2 minutes ago |
not rated yet |
0
Research identifies a way to make cancer cells more responsive to chemotherapy
Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University ...
Cancer
11 hours ago |
5 / 5 (3) |
0
Mayo Clinic genomic analysis lends insight to prostate cancer
Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings ...
Cancer
11 hours ago |
not rated yet |
0
When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs
Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs (miRNAs) before it's dissolved, researchers ...
Cancer
12 hours ago |
not rated yet |
0
|
Improved chemo regimen for childhood leukemia may offer high survival, no added heart toxicity
Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added ...
Cancer
16 hours ago |
not rated yet |
0
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
Motion quotient: IQ predicted by ability to filter motion (w/ video)
A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...
Multiple research teams unable to confirm high-profile Alzheimer's study
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
Scientists discover molecule triggers sensation of itch
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...
Researchers find common childhood asthma unconnected to allergens or inflammation
Little is known about why asthma develops, how it constricts the airway or why response to treatments varies between patients. Now, a team of researchers at Weill Cornell Medical College, Columbia University Medical Center ...
Diabetes' genetic underpinnings can vary based on ethnic background, studies say
Ethnic background plays a surprisingly large role in how diabetes develops on a cellular level, according to two new studies led by researchers at the Stanford University School of Medicine.